application of in vivo induced antigen technology (iviat) to bacillus anthracis应用体内诱导抗原技术(iviat)炭疽杆菌.pdfVIP

Application of In Vivo Induced Antigen Technology (IVIAT) to Bacillus anthracis 1 1 1 2,3 1 Sean M. Rollins *, Amanda Peppercorn , John S. Young , Melissa Drysdale , Andrea Baresch , 1 4 5 6 7 Margaret V. Bikowski , David A. Ashford , Conrad P. Quinn , Martin Handfield , Jeffrey D. Hillman , C. 2 3 1,8,9 1,9,10 Rick Lyons , Theresa M. Koehler , Stephen B. Calderwood , Edward T. Ryan 1 Massachusetts General Hospital, Boston, Massachusetts, United States of America, 2 University of New Mexico Health Science Center, Albuquerque, New Mexico, United States of America, 3 Department of Microbiology and Molecular Genetics, The University of Texas Medical School at Houston, Houston, Texas, United States of America, 4 United States Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), Sao Paulo, Brazil, 5 Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 6 Center for Molecular Microbiology and Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, Florida, United States of America, 7 Oragenics Inc, Alachua, Florida, United States of America, 8 Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts, United States of America, 9 Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America, 10 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Bos